Article
A Prognostic Gene Signature for Hepatocellular Carcinoma
27 Apr 2022
Abstract excerpt
Hepatocellular carcinoma is the third most common cause of cancer-related deaths in China and immune-based therapy can improve patient outcomes. In this study, we investigated the relationship between immunity-associated genes and hepatocellular carcinoma from the prognostic perspective. The data downloaded from The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) and the Gene Expression Omnibus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
